Who
Robert Charles Swanton
Director
Company insider
Files Form 4 as: Director, Bicycle Therapeutics.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $13K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 12 Aug 2025
- Last trade
- 2 Oct 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 6 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $12K3,431 at $3.47 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —3,726 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,453 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,453 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —3,726 at $0.00 | filing |
| 2 Oct 2025filed 6 Oct 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $872102 at $8.55 | filing |
| 12 Aug 2025filed 14 Aug 2025 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 12 Aug 2025filed 14 Aug 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.